Codice QR

The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection

Introduction: Dosing recommendations for paliperidone long-acting injectable antipsychotic (LAIA) do not include oral antipsychotic (OAP) overlap; however, OAPs are often given concurrently despite limited evidence describing both the risks and benefits of this practice. Methods: A retrospective cha...

Descrizione completa

Salvato in:
Autori principali: Trevor A. Stump, PharmD, BCPP, Leigh Anne Nelson, PharmD, BCPP, Yifei Liu, BS Pharm, PhD, Carrie R. Kriz, MS, Courtney A. Iuppa, PharmD, BCPP, Lauren A. Diefenderfer, PharmD, BCPP, Shelby E. Lang, PharmD, BCPP, Ellie S. R. Elliot, PharmD, BCPP, Roger W. Sommi, PharmD, BCPP, FCCP
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Association of Psychiatric Pharmacists 2021-01-01
Serie:Mental Health Clinician
Soggetti:
paliperidone palmitate
long-acting injectable antipsychotic
oral antipsychotic overlap
benztropine
adverse events
decompensation
Accesso online:https://theijpt.org/doi/pdf/10.9740/mhc.2021.01.012
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi